Clinical Trial Update: Characterization of Dermal Reactions in Pediatric Patients With ADHD Using DAYTRANA [Phase 4]

View source ↗

Summary

Phase 4 trial update characterizes dermal reactions in children with ADHD treated with the Daytrana methylphenidate patch. Results were posted in 2009.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• Daytrana (methylphenidate transdermal patch)

Snippet

Sponsor: Noven Therapeutics | Conditions: Attention Deficit Hyperactivity Disorder | Phase 4 | Status: COMPLETED | Results posted: 2009-03-06